Allergy/Asthma News

Adults experienced limited success with oral immunotherapy for food allergies, with about half of a cohort halting treatment within 2 years, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The FDA has approved the use of dupilumab for treating eosinophilic esophagitis in children aged 1 to 11 years who weigh at least 15 kg, according to a press release.

Researchers found low rates of new peanut allergy and generally low rates of peanut discontinuation after introduction in a cohort of high-risk infants, according to study results published in The Journal of Allergy and Clinical Immunology.

Uncontrolled asthma was associated with weekly use of household disinfectants and cleaning products in a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Dupilumab appeared safe for long-term use among patients with moderate to severe asthma or oral corticosteroid-dependent severe asthma, according to data from the TRAVERSE continuation study.

A severe asthma clinic reduced health care utilization and symptom severity for pediatric patients, according to a study published in Annals of Allergy, Asthma & Immunology.

Patients with atopic dermatitis experienced greater risks for asthma, asthma exacerbations and hospitalizations than those without AD, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Patients with type 2 inflammation experienced reductions in asthma exacerbations with dupilumab, with no differences between seasons, according to a study published in Annals of Allergy, Asthma & Immunology.

An immunotherapy comprising seven synthetic peptides may provide a safe and durable alternative to immunotherapies based on whole peanuts, according to a study published in Allergy.

Children who were exposed to opioids prenatally faced greater risks for infection, eczema and dermatitis, and asthma, but not for allergies, anaphylaxis or autoimmune diseases, according to a study published in JAMA Network Open.